Introduction {#sec1-1}
============

In present time, due to modern life style, hectic schedule, stress, and many such reasons, incidence of diseases are increasing, one of them is *Amavata*. The concept of autoimmunity is well-explained under the concept of *Ama*, an intermediate product generated due to the deranged metabolism of digestive fire triggering a chronic inflammatory process in the body. Rheumatoid arthritis is a chronic inflammatory disease. In the whole world, rheumatic disease is the most common cause of physical impairment in society. The lives of more than one million people are physically impaired by rheumatic disorders and one fifth of these are severely disabled. The prevalence rate of this disease is about 3% with a male to female ratio of 1:3.\[[@ref1]\] It occurs throughout the world in all climates and ethnic groups. Till date, about 39 Research activities have been carried out in P.G. Institute, Jamnagar. Previously in Jamnagar, eight activities have been done on Basti, while nine on *Virechana Karma*, and only three on *Kshara Basti*. This number itself suggests its large occurrence and faith of patients in Ayurvedic Management. Only three research activities had been done on *Kshara Basti* in Jamanagar.\[[@ref2]\]

*Shodhana* (bio-purification), *Shamana* (pacification) and *Nidana Parivarjanam* are main modalities of treatment for any disease.\[[@ref3]\] So, in the present study, *Kshara Basti* has been selected as *Shodhana Chikitsa* which is mentioned in *Chikitsa Sutra* described by Chakradatta\[[@ref4]\] and *Nirgundi Ghana Vati* has been selected as *Shamana Chikitsa*.

Aims and Objectives {#sec1-2}
===================

To evaluate the efficacy of "*Kshara Basti* along with *Nirgundi Ghana Vati*" on *Amavata*.To evaluate the efficacy of *Kshara Basti* along with *Nirgundi Ghana Vati* on Heamatological and Bio chemical parameters especially ESR and R.A. Factor (quantitative)test.

Materials and Methods {#sec1-3}
=====================

Total 50 patients fulfilled criteria for diagnosis of the disease *Amavata* (Rheumatoid Arthritis) were selected from the O.P.D. and I.P.D. of Panchakarma Department of I.P.G.T. and R.A., Jamnagar. This study was approved by Institutional Ethics Committee.

Inclusion criteria {#sec2-1}
------------------

Patients having classical features of *Amavata* like *Angamarda, Aruchi, Trishna, Hrillasa, Gaurava, Jwara, Shula, Shotha* etc.\[[@ref5]\] were selected for the present clinical research work. Detailed research proforma was prepared incorporating all the clinical features seen in the disease *Amavata* (Rheumatoid Arthritis).The patients who had fulfilled the revised criteria for Rheumatoid arthritis fixed by the American college of Rheumatology in 1987.\[[@ref6]\]

Rheumatoid factor positive and negative both cases were included.

Exclusion criteria {#sec2-2}
------------------

Chronicity of more than 10 yearsHaving severe crippling deformityHaving cardiac disease, pulmonary tuberculosis and pregnant womenAge less than 18 years and more than 60 years

Plan of study {#sec2-3}
-------------

The selected patients were given *Kshara Basti* along with *Eranda Taila Anuvasana Basti* in format of *Kala Basti*\[[@ref7]\] i.e., 16 days.

*Deepana*, *Pachana* with *Shunthi Churna* for three days*Sarvanga Nirgundi Patra Pinda Sweda* before giving *Basti*After completing *Basti*, *Nirgundi Ghana Vati* 2 tab (500 mg/tab) thrice a day for 30 days. *Nirgundi Ghana Vati* is prepared from *Nirgundi Patra Kwatha*

Total Duration: 46 days.

### Laboratory investigations {#sec3-1}

Rheumatoid Factor (Quantitative) testErythrocyte Sedimentation Rate by Westergren methodSerum uric acid (for exclusion)X-ray of the affected jointRoutine urine, blood examination

### Criteria for assessment {#sec3-2}

The results of therapy were assessed on the basis of clinical features of the disease *Amavata*, which are mentioned in Ayurvedic classic as well as with the help of criteria fixed by American Rheumatism Association in 1987. The scoring pattern adopted for assessment of clinical features is as follows:
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Observation and Results {#sec1-4}
=======================

Effect of therapy on chief complaints such as *Sandhishoola, Sandhishotha, Sandhistabdhata* and *Sandhisparsa Asahyata* is found to be statistically highly significant (P\>0.001) \[[Table 1](#T1){ref-type="table"}\]. Also statistically highly significant (P\>0.001) results were found on general symptoms such as *Angamarda, Aruchi*, etc.; associated symptoms such as *Daurbalya, Agnimandya, Praseka*, etc. and on functional capacity parameters \[Tables [2](#T2){ref-type="table"}--[4](#T4){ref-type="table"}\].

###### 

Effect on chief complaints
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Effect on general symptoms
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###### 

Effect on associated symptoms
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###### 

Effect on functional capacity
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The retention time of *Kshara Basti* upto 5mins was observed in maximum number of patients (60%) and retention time of *Anuvasana Basti* - 3 to 6 hrs was observed in 62.22% patients \[Tables [5](#T5){ref-type="table"}[6](#T6){ref-type="table"}\].

###### 

Effect on ESR
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###### 

Effect on rheumatoid factor
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The effect of therapy on Erythrocyte sedimentation rate and RA factor (Quantitave) was found to be statistically highly significant (P\>0.001)and significant(P\>0.01) respectively \[Tables [7](#T7){ref-type="table"}[8](#T8){ref-type="table"}\].

###### 

Retention time of *Kshara Basti*
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###### 

Retention time of *Anuvasana Basti*
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In overall effect of therapy maximum number of patients (40%) got moderate improvement \[[Chart 1](#F1){ref-type="fig"}\].
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Discussion {#sec1-5}
==========

Maximum number of patients (40%) belonged to the age group of 41-50 years, which shows its predominance in the middle age group. This data is slightly in accordance with the modern findings, that the onset is most frequent during the fourth and fifth decades of life with 80% of all patients developing disease between the age of 35 and 50 years. In this study, majority of the patients were female (91.11%) as compared to male. Textual references also reflect the predominance of rheumatoid arthritis in females. Majority of the patients were having *Mandagni* (97.77%). *Mandagni* is the root of all the disease, particularly of *Amavata*. In the present study, majority of the patients had *Madhyama* (46.66%) and *Krura Kostha* (57.77%). It justifies the finding of *Prakriti*. The study reveals that maximum number of patients possesses *Vata Pitta Prakriti* i.e., 48.88%. According to *Acharya Vagabhata, Dwidoshaja Prakriti* is *Nindya, Hemadri* gives commentary on that *Vata-Pitta Prakriti* is *Hinatama*, persons who having this *Prakriti*, are more prone to disease.\[[@ref8]\] Maximum numbers of patients were having history of gradual onset (86%) and chronicity of \<2 years (51%). The disease runs a chronic course and also becomes chronic due to the non-availability of good treatment in contemporary medicine. It may be due to the fact that *Amavata* is a chronic disease and usually manifests itself over a period of a few months. Most of the patients were found to be indulged in *Viruddha Ahara* (93%), *Atiguru* (63%), *Visamashana* (42%), *Snigdha Ahara* (40%), *Divasvapna* (66%), *Nischalatva* (55%), *Bhojanottara Vyayama* (31%), *Chinta* (69%). All these factors lead to *Mandagni* and consequently to formation of *Ama*. So, it can be concluded that all the above mentioned factors play an important role in precipitation and aggravation of the disease *Amavata*. These data also support the etiology of *Amavata*, mentioned in classics. *Kshara Basti* comprises of *Saindhava, Guda, Chincha, Shatahva* and *Gomutra*. In this *Basti*, maximum quantity is of *Gomutra*, which is having *Kshara Guna*. *Kshara* has the property of *Lekhana* and *Vishoshana*,\[[@ref9]\] which are antagonistic to *Ama* and is very much required in the conditions like *Amavata*. But it must be kept in the mind that, it may further vitiate *Vata*. Thus, keeping this view in mind *Eranda Taila Anuvasana* was given in the format of Kala Basti. Eranda has a typical property of *Ama Pachana*.\[[@ref10]\] *Chincha* to be taken in *Kshara Basti* should be in *Pakva* stage that is having *Vata-Kapha Shamaka*\[[@ref11]\] property. Regarding *Purana Guda* to be used, it is *Laghu, Pathya, Annabhishyandi, Agnivardhaka* and *Vata-Pittaghna*.\[[@ref12]\] *Saindhava* due to its *Sukshma* and *Tikshna*\[[@ref13]\] property helps the *Basti Dravya* to reach up to the molecular level. It is capable of liquefying the viscid matter and breaking it into minute particles. Thus solves both the purpose; to curing the disease and to purify the body. *Nirgundi Ghana Vati*, which was given after *Basti* has a definite action on vitiated *Vata Kapha Dosha*. Specially, *Tikta* and *Katu Rasa* present in *Nirgundi* possess the antagonistic properties to that of *Ama* and *Kapha* which are the chief causative factors in this disease. Because of their *Agnivriddhikara* property they increase digestive power which also digests *Amarasa* and reduces excessive production of *Kapha* and also removes the obstruction of the *Srotas*. Because of *Tikshna Guna* and *Ushna Virya* it also alleviates vitiated *Vata* and reduces *Srotorodha* and pain. Thus *Nirgundi* controls *Ama* and *Vata* together and minimize the process of pathogenesis. *Chincha, Gomutra, Shatahva, Nirgundi* have anti-oxidant and anti-inflammatory properties, which reduces inflammatory process in the body.

Conclusion {#sec1-6}
==========

Lastly, it can be concluded that *Amavata* looks similar to Rheumatoid Arthritis in its clinical appearance and *Kshara Basti* along with *Nirgundi Ghana Vati* is effective in the treatment of *Amavata*. Also, it gives significant results on rheumatoid factor and highly significant result on ESR which is used for diagnosis of rheumatoid arthritis.
